Takara Bio USA, Inc RetroNectin® GMP grade reagent
Contract Opportunity Analysis
Presolicitation HEALTH AND HUMAN SERVICES, DEPARTMENT OF NATIONAL INSTITUTES OF HEALTH is planning to procure Takara Bio USA, Inc RetroNectin® GMP grade reagent. This reagent is typically used in the development, evaluation, and validation of investigational new drugs (INDs) for cellular therapies and the manufacture of cellular therapy products for approved clinical trials. The Center of Cellular Engineering, an AABB accredited cellular therapy laboratory, intends to purchase 30 vials of RetroNectin® GMP grade reagent from Takara Bio USA, Inc. The reagent will be used in the manufacturing process of clinical T-cells for the treatment of NIH CC patients with various medical conditions. The acquisition will be conducted using simplified acquisition procedures, and interested parties may submit their capabilities and interest in response to this notice. The closing date for submissions is December 23, 2023, at 12:00 pm EST.